Joel Habener, Breakthrough Prize in Life Sciences Laureate, Passes Away

The Breakthrough Prize Foundation is saddened by the passing of 2025 laureate Joel Habener at the age of 88. As a physician-scientist his seminal research identified the GLP-1 hormone, which led to the development of medicines which have transformed the treatment of diabetes and obesity. The Breakthrough Prize offers its condolences his family, friends and colleagues.